These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11438554)

  • 1. Gene therapy for antiangiogenesis.
    Kleinman HK; Liau G
    J Natl Cancer Inst; 2001 Jul; 93(13):965-7. PubMed ID: 11438554
    [No Abstract]   [Full Text] [Related]  

  • 2. Researchers target tumour blood vessels with antiangiogenic gene therapy.
    Frankish H
    Lancet; 2002 Jun; 359(9325):2256. PubMed ID: 12103296
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer gene therapy targeting angiogenesis: an updated review.
    Liu CC; Shen Z; Kung HF; Lin MC
    World J Gastroenterol; 2006 Nov; 12(43):6941-8. PubMed ID: 17109514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based delivery systems for antiangiogenic therapy.
    Machluf M; Carroll RS
    Biotechnol Genet Eng Rev; 2003; 20():183-95. PubMed ID: 14997852
    [No Abstract]   [Full Text] [Related]  

  • 5. Fishing for a cure. Does the tiny zebrafish hold a key to stopping tumor growth?
    Kiser K
    Minn Med; 2005 Apr; 88(4):8-9. PubMed ID: 15940882
    [No Abstract]   [Full Text] [Related]  

  • 6. Modeling antiangiogenesis gene therapy.
    Tsai JH; Lee WM
    Cancer Biol Ther; 2002; 1(5):554-5. PubMed ID: 12496488
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiangiogenesis: new frontiers in therapeutic development.
    LaMontagne KR
    Angiogenesis; 2005; 8(4):285-7. PubMed ID: 16400519
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting tumor angiogenesis with gene therapy.
    Chen QR; Zhang L; Gasper W; Mixson AJ
    Mol Genet Metab; 2001; 74(1-2):120-7. PubMed ID: 11592809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation.
    Kubota T; Taiyoh H; Matsumura A; Murayama Y; Ichikawa D; Okamoto K; Fujiwara H; Ikoma H; Nakanishi M; Kikuchi S; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Suzuki Y; Matsumoto K; Nakamura T; Otsuji E
    Int J Cancer; 2009 Dec; 125(12):2879-86. PubMed ID: 19588506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future prospects and challenges of antiangiogenic cancer gene therapy.
    Samaranayake H; Määttä AM; Pikkarainen J; Ylä-Herttuala S
    Hum Gene Ther; 2010 Apr; 21(4):381-96. PubMed ID: 20163246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is angiogenesis an organizing principle in biology and medicine?
    Folkman J
    J Pediatr Surg; 2007 Jan; 42(1):1-11. PubMed ID: 17208533
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy strategies for tumor antiangiogenesis.
    Kong HL; Crystal RG
    J Natl Cancer Inst; 1998 Feb; 90(4):273-86. PubMed ID: 9486813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer research. Obstacle for promising cancer therapy.
    Marx J
    Science; 2002 Feb; 295(5559):1444. PubMed ID: 11859164
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular predictors of response to antiangiogenesis therapies.
    Gerger A; LaBonte M; Lenz HJ
    Cancer J; 2011; 17(2):134-41. PubMed ID: 21427557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular normalization: study examines how antiangiogenesis therapies work.
    Webb T
    J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiangiogenesis: the fifth cancer treatment modality?
    Camp-Sorrell D
    Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
    Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
    Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenics meet nanotechnology.
    Ruoslahti E
    Cancer Cell; 2002 Aug; 2(2):97-8. PubMed ID: 12204528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning on the angiogenic microswitch.
    Eilken HM; Adams RH
    Nat Med; 2010 Aug; 16(8):853-4. PubMed ID: 20689545
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
    Folkman J
    Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.